Despite poor growth, the company's P/E ratio matches the market's, indicating investor hope for business turnaround. If recent earnings trends persist, the share price may drop, making the current P/E ratio unsustainable.
Contec's reinvestment for growth leading to higher sales is promising despite short-term lower returns. However, given the company's prospects and 2 warning signs, detailed study is advisable before investment.
Contec Medical Systemsに関するコメント
まだコメントはありません